RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Schonfeld Strategic Advisors LLC's Holding History (CIK: 0001665241)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 21,371 Value ($000) $108 Avg Close $4.91 Range $3.79 - $6.11

Q4 2024

Shares 54,511 Value ($000) $368 Avg Close $6.72 Range $5.60 - $9.55

Q4 2022

Shares 81,204 Value ($000) $626 Avg Close $9.81 Range $7.04 - $13.29

Q3 2022

Shares 117,011 Value ($000) $1,244 Avg Close $10.13 Range $7.48 - $14.18

Q2 2022

Shares 172,195 Value ($000) $1,402 Avg Close $6.69 Range $4.92 - $9.40

Q1 2022

Shares 90,800 Value ($000) $650 Avg Close $10.63 Range $5.80 - $18.23

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	21,371	$108	$4.91	$3.79 - $6.11
Q4 2024	54,511	$368	$6.72	$5.60 - $9.55
Q4 2022	81,204	$626	$9.81	$7.04 - $13.29
Q3 2022	117,011	$1,244	$10.13	$7.48 - $14.18
Q2 2022	172,195	$1,402	$6.69	$4.92 - $9.40
Q1 2022	90,800	$650	$10.63	$5.80 - $18.23